Skip to main content

Advertisement

Log in

Gender, Mental Health, and Entry Into Care with Advanced HIV Among People Living with HIV in Cameroon Under a National ‘Treat All’ Policy

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Delays in diagnosis and linkage to HIV care persist among people living with HIV (PLWH), even after expanded access to ART worldwide. Mental health may influence timely linkage to HIV care. Greater understanding of the relationship among gender, mental health, and delayed linkage to HIV care can inform strategies to improve the health of PLWH. We interviewed 426 PLWH initiating HIV care in Cameroon between June 2019 and March 2020 to estimate the prevalence of depression, anxiety, and post-traumatic stress disorder (PTSD) and the association between mental health and entry into care with advanced HIV. Separate multivariable log binomial regression models were used to estimate the association between mental health exposure and entry into HIV care with advanced HIV. Stratified analyses were used to assess effect modification by gender. Approximately 20, 15, and 12% of participants reported symptoms of depression, PTSD, and anxiety, respectively. The prevalence of mental health symptoms did not vary significantly by gender. Overall, 53% of participants enrolled in HIV care with advanced HIV: 51% of men and 54% of women. Screening positive for one of the mental health disorders assessed was associated with greater prevalence of enrollment with advanced HIV among men, but not among women. Future research should examine gender-specific pathways between mental health symptoms and entry into care with advanced HIV, particularly for men in Cameroon. The extent to which untreated mental health symptoms drive gender disparities throughout the HIV care continuum should be explored further.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data Availability

The dataset contains sensitive information and is not publicly available. However, it could be made available from the first author (AMP) on reasonable request, with approval from the IRB at the University of North Carolina at Chapel Hill to maintain confidentiality.

Code Availability

All analyses were conducted using SAS. SAS code could be made available from the first author (AMP) on reasonable request.

References

  1. World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization; 2015.

    Google Scholar 

  2. Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807.

    CAS  PubMed  Google Scholar 

  3. Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, et al. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;373(9):808–22.

    CAS  PubMed  Google Scholar 

  4. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Iwuji CC, Orne-Gliemann J, Larmarange J, Okesola N, Tanser F, Thiebaut R, et al. Uptake of home-based HIV testing, linkage to care, and community attitudes about ART in Rural KwaZulu-Natal, South Africa: descriptive results from the first phase of the ANRS 12249 TasP cluster-randomised trial. PLoS Med. 2016;13(8):e1002107.

    PubMed  PubMed Central  Google Scholar 

  6. Nash D, Robertson M. How to evolve the response to the global HIV epidemic with new metrics and targets based on pre-treatment CD4 counts. Curr HIV/AIDS Rep. 2019;16(4):304–13.

    PubMed  Google Scholar 

  7. Grangeiro A, Escuder MM, Menezes PR, Alencar R, de Ayres Castilho E. Late entry into HIV care: estimated impact on AIDS mortality rates in Brazil, 2003–2006. PLoS ONE. 2011;6(1):e14585.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Krawczyk CS, Funkhouser E, Kilby JM, Kaslow RA, Bey AK, Vermund SH. Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic. South Med J. 2006;99(5):472–81.

    PubMed  PubMed Central  Google Scholar 

  9. Haskew J, Turner K, Rø G, Ho A, Kimanga D, Sharif S. Stage of HIV presentation at initial clinic visit following a community-based HIV testing campaign in rural Kenya. BMC Public Health. 2015;15:16.

    PubMed  PubMed Central  Google Scholar 

  10. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Gesesew HA, Tesfay Gebremedhin A, Demissie TD, Kerie MW, Sudhakar M, Mwanri L. Significant association between perceived HIV related stigma and late presentation for HIV/AIDS care in low and middle-income countries: a systematic review and meta-analysis. PLoS ONE. 2017;12(3):e0173928.

    PubMed  PubMed Central  Google Scholar 

  12. Gelaw YA, Senbete GH, Adane AA, Alene KA. Determinants of late presentation to HIV/AIDS care in Southern Tigray Zone, Northern Ethiopia: an institution based case-control study. AIDS Res Ther. 2015;12:40.

    PubMed  PubMed Central  Google Scholar 

  13. Abaynew Y, Deribew A, Deribe K. Factors associated with late presentation to HIV/AIDS care in South Wollo ZoneEthiopia: a case-control study. AIDS Res Ther. 2011;8:8.

    PubMed  PubMed Central  Google Scholar 

  14. Takuva S, Brown AE, Pillay Y, Delpech V, Puren AJ. The continuum of HIV care in South Africa: implications for achieving the second and third UNAIDS 90–90-90 targets. AIDS. 2017;31(4):545–52.

    PubMed  Google Scholar 

  15. Nsanzimana S, Kanters S, Remera E, Forrest JI, Binagwaho A, Condo J, et al. HIV care continuum in Rwanda: a cross-sectional analysis of the national programme. Lancet HIV. 2015;2(5):e208–15.

    PubMed  Google Scholar 

  16. Lippman SA, Shade SB, El Ayadi AM, Gilvydis JM, Grignon JS, Liegler T, et al. Attrition and opportunities along the HIV care continuum: findings from a population-based sample, North West Province, South Africa. J Acquir Immune Defic Syndr. 2016;73(1):91–9.

    PubMed  PubMed Central  Google Scholar 

  17. Cornell M, Cox V, Wilkinson L. Public health blindness towards men in HIV programmes in Africa. Trop Med Int Health. 2015;20(12):1634–5.

    PubMed  Google Scholar 

  18. Osler M, Cornell M, Ford N, Hilderbrand K, Goemaere E, Boulle A. Population-wide differentials in HIV service access and outcomes in the Western Cape for men as compared to women, South Africa: 2008 to 2018: a cohort analysis. J Int AIDS Soc. 2020;23(Suppl 2):e25530.

    PubMed  PubMed Central  Google Scholar 

  19. Cornell M, McIntyre J, Myer L. Men and antiretroviral therapy in Africa: our blind spot. Trop Med Int Health. 2011;16(7):828–9.

    PubMed  PubMed Central  Google Scholar 

  20. Brandt R. The mental health of people living with HIV/AIDS in Africa: a systematic review. Afr J AIDS Res. 2009;8(2):123–33.

    PubMed  Google Scholar 

  21. Nanni MG, Caruso R, Mitchell AJ, Meggiolaro E, Grassi L. Depression in HIV infected patients: a review. Curr Psychiatry Rep. 2015;17(1):530.

    PubMed  Google Scholar 

  22. Bernard C, Dabis F, de Rekeneire N. Prevalence and factors associated with depression in people living with HIV in sub-Saharan Africa: a systematic review and meta-analysis. PLoS ONE. 2017;12(8):e0181960.

    PubMed  PubMed Central  Google Scholar 

  23. Rane MS, Hong T, Govere S, Thulare H, Moosa M-Y, Celum C, et al. Depression and anxiety as risk factors for delayed care-seeking behavior in human immunodeficiency virus-infected individuals in South Africa. Clin Infect Dis. 2018;67(9):1411–8.

    PubMed  PubMed Central  Google Scholar 

  24. Choi KW, Sikkema KJ, Velloza J, Marais A, Jose C, Stein DJ, et al. Maladaptive coping mediates the influence of childhood trauma on depression and PTSD among pregnant women in South Africa. Arch Womens Ment Health. 2015;18(5):731–8.

    PubMed  PubMed Central  Google Scholar 

  25. Myer L, Smit J, Roux LL, Parker S, Stein DJ, Seedat S. Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care STDs. 2008;22(2):147–58.

    PubMed  Google Scholar 

  26. Nakimuli-Mpungu E, Bass JK, Alexandre P, Mills EJ, Musisi S, Ram M, et al. Depression, alcohol use and adherence to antiretroviral therapy in sub-Saharan Africa: a systematic review. AIDS Behav. 2012;16(8):2101–18.

    PubMed  Google Scholar 

  27. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study. J Am Med Assoc. 2001;285(11):1466–74.

    CAS  Google Scholar 

  28. Memiah P, Shumba C, Etienne-Mesubi M, Agbor S, Hossain MB, Komba P, et al. The effect of depressive symptoms and CD4 count on adherence to highly active antiretroviral therapy in sub-Saharan Africa. J Int Assoc Provid AIDS Care. 2014;13(4):346–52.

    PubMed  Google Scholar 

  29. Tao J, Vermund SH, Lu H, Ruan Y, Shepherd BE, Kipp AM, et al. Impact of depression and anxiety on initiation of antiretroviral therapy among men who have sex with men with newly diagnosed HIV infections in China. AIDS Patient Care STDs. 2017;31(2):96–104.

    PubMed  PubMed Central  Google Scholar 

  30. Prabhu S, McFall AM, Mehta SH, Srikrishnan AK, Kumar MS, Anand S, et al. Psychosocial barriers to viral suppression in a community-based sample of human immunodeficiency virus-infected men who have sex with men and people who inject drugs in India. Clin Infect Dis. 2020;70(2):304–13.

    PubMed  Google Scholar 

  31. Govender K, Durevall D, Cowden RG, Beckett S, Kharsany AB, Lewis L, et al. Depression symptoms, HIV testing, linkage to ART, and viral suppression among women in a high HIV burden district in KwaZulu-Natal, South Africa: a cross-sectional household study. J Health Psychol. 2020. https://doi.org/10.1177/1359105320982042.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Onono M, Odwar T, Abuogi L, Owuor K, Helova A, Bukusi E, et al. Effects of depression, stigma and intimate partner violence on postpartum women’s adherence and engagement in HIV care in Kenya. AIDS Behav. 2020;24(6):1807–15.

    PubMed  PubMed Central  Google Scholar 

  33. Tlhajoane M, Eaton JW, Takaruza A, Rhead R, Maswera R, Schur N, et al. Prevalence and associations of psychological distress, HIV infection and HIV care service utilization in East Zimbabwe. AIDS Behav. 2018;22(5):1485–95.

    PubMed  Google Scholar 

  34. Wagner GJ, Slaughter M, Ghosh-Dastidar B. Depression at treatment initiation predicts HIV antiretroviral adherence in Uganda. J Int Assoc Provid AIDS Care. 2017;16(1):91–7.

    PubMed  Google Scholar 

  35. UNAIDS. Country overview: Cameroon. Geneva: UNAIDS; 2020.

    Google Scholar 

  36. Chammartin F, Dao Ostinelli CH, Anastos K, Jaquet A, Brazier E, Brown S, et al. International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012–2019. BMJ Open. 2020;10(5):e035246.

    PubMed  PubMed Central  Google Scholar 

  37. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Pence BW, Gaynes BN, Atashili J, O’Donnell JK, Tayong G, Kats D, et al. Validity of an interviewer-administered patient health questionnaire-9 to screen for depression in HIV-infected patients in Cameroon. J Affect Disord. 2012;143(1–3):208–13.

    PubMed  PubMed Central  Google Scholar 

  39. Monahan PO, Shacham E, Reece M, Kroenke K, Ong’or WO, Omollo O, et al. Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in western Kenya. J Gen Intern Med. 2009;24(2):189–97.

    PubMed  Google Scholar 

  40. Akena D, Joska J, Obuku EA, Stein DJ. Sensitivity and specificity of clinician administered screening instruments in detecting depression among HIV-positive individuals in Uganda. AIDS Care. 2013;25(10):1245–52.

    PubMed  Google Scholar 

  41. Carballeira Y, Dumont P, Borgacci S, Rentsch D, de Tonnac N, Archinard M, et al. Criterion validity of the French version of patient health questionnaire (PHQ) in a hospital department of internal medicine. Psychol Psychother. 2007;80(Pt 1):69–77.

    PubMed  Google Scholar 

  42. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.

    PubMed  Google Scholar 

  43. Chibanda D, Verhey R, Gibson LJ, Munetsi E, Machando D, Rusakaniko S, et al. Validation of screening tools for depression and anxiety disorders in a primary care population with high HIV prevalence in Zimbabwe. J Affect Disord. 2016;198:50–5.

    PubMed  Google Scholar 

  44. Zhong QY, Gelaye B, Zaslavsky AM, Fann JR, Rondon MB, Sánchez SE, et al. Diagnostic validity of the generalized anxiety disorder—7 (GAD-7) among pregnant women. PLoS ONE. 2015;10(4):e0125096.

    PubMed  PubMed Central  Google Scholar 

  45. Ruiz MA, Zamorano E, García-Campayo J, Pardo A, Freire O, Rejas J. Validity of the GAD-7 scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care. J Affect Disord. 2011;128(3):277–86.

    PubMed  Google Scholar 

  46. Micoulaud-Franchi JA, Lagarde S, Barkate G, Dufournet B, Besancon C, Trébuchon-Da Fonseca A, et al. Rapid detection of generalized anxiety disorder and major depression in epilepsy: validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample. Epilepsy Behav. 2016;57(Pt A):211–6.

    PubMed  Google Scholar 

  47. Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The posttraumatic stress disorder checklist for DSM-5 (PCL-5): development and initial psychometric evaluation. J Trauma Stress. 2015;28(6):489–98.

    PubMed  Google Scholar 

  48. Bovin MJ, Marx BP, Weathers FW, Gallagher MW, Rodriguez P, Schnurr PP, et al. Psychometric properties of the PTSD checklist for diagnostic and statistical manual of mental disorders-fifth edition (PCL-5) in veterans. Psychol Assess. 2016;28(11):1379–91.

    PubMed  Google Scholar 

  49. Verhey R, Chibanda D, Gibson L, Brakarsh J, Seedat S. Validation of the posttraumatic stress disorder checklist—5 (PCL-5) in a primary care population with high HIV prevalence in Zimbabwe. BMC Psychiatry. 2018;18(1):109.

    PubMed  PubMed Central  Google Scholar 

  50. Ibrahim H, Ertl V, Catani C, Ismail AA, Neuner F. The validity of posttraumatic stress disorder checklist for DSM-5 (PCL-5) as screening instrument with Kurdish and Arab displaced populations living in the Kurdistan region of Iraq. BMC Psychiatry. 2018;18(1):259.

    PubMed  PubMed Central  Google Scholar 

  51. Ashbaugh AR, Houle-Johnson S, Herbert C, El-Hage W, Brunet A. Psychometric validation of the English and French versions of the posttraumatic stress disorder checklist for DSM-5 (PCL-5). PLoS ONE. 2016;11(10):e0161645.

    PubMed  PubMed Central  Google Scholar 

  52. Ballard T, Coates J, Swindale A, Deitchler M. Household hunger scale: indicator definition and measurement guide. Washington DC: Food and Nutrition Technical Assistance II Project, FHI; 2011. p. 360.

    Google Scholar 

  53. USAID. Fanta III Food and Nutrition Technical Asstance. Household hunger scale: indicator definition and measurement guide. 2011. https://www.fantaproject.org/sites/default/files/resources/HHS-Indicator-Guide-Aug2011.pdf

  54. Asangbeh SL, Sobngwi JL, Ekali GL, Eyoum C, Msellati P. Predictors of depression among patients on art in a rural health district in North West Cameroon. AIDS Care. 2016;28(2):205–8.

    PubMed  Google Scholar 

  55. Pefura-Yone EW, Soh E, Kengne AP, Balkissou AD, Kuaban C. Non-adherence to antiretroviral therapy in Yaounde: prevalence, determinants and the concordance of two screening criteria. J Infect Public Health. 2013;6(4):307–15.

    PubMed  Google Scholar 

  56. Wallace S, Mactaggart I, Banks LM, Polack S, Kuper H. Association of anxiety and depression with physical and sensory functional difficulties in adults in five population-based surveys in low and middle-income countries. PLoS ONE. 2020;15(6):e0231563.

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Luma HN, Jua P, Donfack O-T, Kamdem F, Ngouadjeu E, Mbatchou HB, et al. Late presentation to HIV/AIDS care at the Douala general hospital, Cameroon: its associated factors, and consequences. BMC Infect Dis. 2018;18(1):298.

    PubMed  PubMed Central  Google Scholar 

  58. Parcesepe AM, Mugglin C, Nalugoda F, Bernard C, Yunihastuti E, Althoff K, et al. Screening and management of mental health and substance use disorders in HIV treatment settings in low- and middle-income countries within the global IeDEA consortium. J Int AIDS Soc. 2018;21(3):e25101.

    PubMed  PubMed Central  Google Scholar 

  59. Kaaya S, Eustache E, Lapidos-Salaiz I, Musisi S, Psaros C, Wissow L. Grand challenges: Improving HIV treatment outcomes by integrating interventions for co-morbid mental illness. PLoS Med. 2013;(10)5:e1001447

  60. Mulango ID, Atashili J, Gaynes BN, Njim T. Knowledge, attitudes and practices regarding depression among primary health care providers in Fako division, Cameroon. BMC Psychiatry. 2018;18(1):66.

    PubMed  PubMed Central  Google Scholar 

Download references

Funding

This research was supported by NIMH Grant K01 MH114721, NICHD Grant P2C HD050924 (Carolina Population Center), NIAID Grant P30 AI050410 (UNC Center for AIDS Research), and NIAID Grant U01AI096299. This work is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions mentioned above.

Author information

Authors and Affiliations

Authors

Contributions

AP: Conceptualization, funding, analysis, Writing—original draft; LF: Analysis; Writing—review & editing; PVE: Project administration; Writing—review & editing; AD: Project administration; Supervision; Writing—review & editing; RA: Writing—review & editing; MW: Conceptualization; Writing—review & editing; BP: Conceptualization; Writing—review & editing; EP: Project administration; Writing—review & editing; MY: Writing—Review & editing; DNsame: Writing—Review & editing; KA: Writing—review & editing; DNash: Conceptualization; Writing—review & editing.

Corresponding author

Correspondence to Angela M. Parcesepe.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

This study was approved by the Institutional Review Board at the University of North Carolina at Chapel Hill and the National Ethical Committee of Research for Human Health in Cameroon.

Informed Consent

All participants provided written informed consent.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 17 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Parcesepe, A.M., Filiatreau, L.M., Ebasone, P.V. et al. Gender, Mental Health, and Entry Into Care with Advanced HIV Among People Living with HIV in Cameroon Under a National ‘Treat All’ Policy. AIDS Behav 25, 4018–4028 (2021). https://doi.org/10.1007/s10461-021-03328-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-021-03328-3

Keywords

Navigation